1Iwai K, TashimaM, Itoh M, et al. Fulminant hepatitis B following bone marrow transplantation in an HBsAg- negative, HbsAb- positive recipient; reactivation of dormant virus during the immunosuppressive period[J].Bone Marrow Transplant, 2000,25:105 - 108.
2McClary H, Koch R, Chisari FV, etal. Inhibition of hepatitis B virus replication during schistosoma mansoni infection in transgenic mice[J]. J Exp Med, 2000,192:289-294.
3Fukai K, Yokosuka O, Fujiwara K, et al. Etiologic considerations of fulminant non - A, non - B viral hepatitis in Japan: analysis by nucleic acid amplification method[J]. Infect Dis, 1998, 178:325 - 333.
4Kosly, Raien. Hepatitis B virus: Molecular mechanisms in disease and hovel strategies for therapy[M]. Imperial College Press: Distributed by world Scientific. c 1998.
5Michalak TI: Occult persistence and lymphotropism of hepadnairal infection: insight from the wookchuck viral hepatitis model[J]. Immunological Review, 2000,174:98 - 111.
6Doitsh G, Shaul Y. HBV transcription repression in response to genotoxic stress in p53 - dependent and abroganted by pX[J]. Oncogene, 1999,18:7506-7513.
7Nehrbass D, Klinek F, Bannasch P. Overexpression of insulin receptor substrate - 1 emerges early in hepatocarcinogenesis and elicits preneoplastic hepatic glycogenosis[J] .Am J Pathol, 1998, 152:341 - 345.
8Brechot C, Thiers V, Kremsdor D, et al. Persistent hepatitis B virus infection in subjects without hepatitisB surface antigen: clinically significant or purely ""occult""? [J].Hepatitis, 2001,34:194- 203.
9Cacciola I, Pollicino T, SquadritoG, et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease[J]. Nengl J Med, 1999, 341:22-26.
10Saraswat S, Banerjee K, Chaudhury N, et al. Post - transfusion hepatitis type B following multiple transfusions of HBsAg - negative blood [J].Hepatol, 1996, 25:639-643.
